Prediction of molecular interactions and physicochemical properties relevant for vasopressin V2 receptor antagonism. 2022

Ania de la Nuez Veulens, and Yoanna M Álvarez Ginarte, and Rolando E Rodríguez Fernandez, and Fabrice Leclerc, and Luis A Montero Cabrera
Department of Biochemistry, Faculty of Biology, University of Havana, Havana, Cuba. ania.delanuez@fbio.uh.cu.

We have developed two ligand- and receptor-based computational approaches to study the physicochemical properties relevant to the biological activity of vasopressin V2 receptor (V2R) antagonist and eventually to predict the expected binding mode to V2R. The obtained quantitative structure activity relationship (QSAR) model showed a correlation of the antagonist activity with the hydration energy (EH2O), the polarizability (P), and the calculated partial charge on atom N7 (q6) of the common substructure. The first two descriptors showed a positive contribution to antagonist activity, while the third one had a negative contribution. V2R was modeled and further relaxed on a 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocoline (POPC) membrane by molecular dynamics simulations. The receptor antagonist complexes were guessed by molecular docking, and the stability of the most relevant structures was also evaluated by molecular dynamics simulations. As a result, amino acid residues Q96, W99, F105, K116, F178, A194, F307, and M311 were identified with the probably most relevant antagonist-receptor interactions on the studied complexes. The proposed QSAR model could explain the molecular properties relevant to the antagonist activity. The contributions to the antagonist-receptor interaction appeared also in agreement with the binding mode of the complexes obtained by molecular docking and molecular dynamics. These models will be used in further studies to look for new V2R potential antagonist molecules.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D000465 Algorithms A procedure consisting of a sequence of algebraic formulas and/or logical steps to calculate or determine a given task. Algorithm
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D016000 Cluster Analysis A set of statistical methods used to group variables or observations into strongly inter-related subgroups. In epidemiology, it may be used to analyze a closely grouped series of events or cases of disease or other health-related phenomenon with well-defined distribution patterns in relation to time or place or both. Clustering,Analyses, Cluster,Analysis, Cluster,Cluster Analyses,Clusterings

Related Publications

Ania de la Nuez Veulens, and Yoanna M Álvarez Ginarte, and Rolando E Rodríguez Fernandez, and Fabrice Leclerc, and Luis A Montero Cabrera
January 1998, Acta biochimica Polonica,
Ania de la Nuez Veulens, and Yoanna M Álvarez Ginarte, and Rolando E Rodríguez Fernandez, and Fabrice Leclerc, and Luis A Montero Cabrera
December 2005, Harefuah,
Ania de la Nuez Veulens, and Yoanna M Álvarez Ginarte, and Rolando E Rodríguez Fernandez, and Fabrice Leclerc, and Luis A Montero Cabrera
October 1998, The Journal of biological chemistry,
Ania de la Nuez Veulens, and Yoanna M Álvarez Ginarte, and Rolando E Rodríguez Fernandez, and Fabrice Leclerc, and Luis A Montero Cabrera
November 2017, Chemical biology & drug design,
Ania de la Nuez Veulens, and Yoanna M Álvarez Ginarte, and Rolando E Rodríguez Fernandez, and Fabrice Leclerc, and Luis A Montero Cabrera
August 2001, Cardiovascular research,
Ania de la Nuez Veulens, and Yoanna M Álvarez Ginarte, and Rolando E Rodríguez Fernandez, and Fabrice Leclerc, and Luis A Montero Cabrera
January 2020, Vitamins and hormones,
Ania de la Nuez Veulens, and Yoanna M Álvarez Ginarte, and Rolando E Rodríguez Fernandez, and Fabrice Leclerc, and Luis A Montero Cabrera
August 2002, Journal of molecular endocrinology,
Ania de la Nuez Veulens, and Yoanna M Álvarez Ginarte, and Rolando E Rodríguez Fernandez, and Fabrice Leclerc, and Luis A Montero Cabrera
May 1998, Journal of computer-aided molecular design,
Ania de la Nuez Veulens, and Yoanna M Álvarez Ginarte, and Rolando E Rodríguez Fernandez, and Fabrice Leclerc, and Luis A Montero Cabrera
September 1997, Current opinion in nephrology and hypertension,
Ania de la Nuez Veulens, and Yoanna M Álvarez Ginarte, and Rolando E Rodríguez Fernandez, and Fabrice Leclerc, and Luis A Montero Cabrera
August 2021, Cell research,
Copied contents to your clipboard!